Follow-up: Prozac intrigue fizzles

In February (, Updates reported an accusation made by the British Medical Journal (BMJ) that pharmaceutical manufacturer Eli Lilly & Co. had concealed documents linking the company's antidepressant Prozac (fluoxetine) to a heightened risk of suicide. Updates noted that Lilly denied the allegation but, regrettably, the February issue of Contemporary Pediatrics had already gone to press when BMJ editors retracted their statement and apologized to Lilly: "The BMJ accepts that Eli Lilly acted properly in relation to the disclosure of these documents ... and is happy to set the record straight and apologize."

Related Videos
J. Thomas Megerian, MD, PhD, FAAP | Author provided
Jonathan Miller, MD
Steven Selbst, MD
Rana Hamdy, MD | Image Credit: Children's National
Steven Selbst, MD
Erica Sood, MD | Image Credit: Nemours
© 2023 MJH Life Sciences

All rights reserved.